Literature DB >> 7275009

Synthesis of a 21-residue fragment of human proinsulin by the polyamide solid phase method.

E Atherton, W Hübscher, R C Sheppard, V Woolley.   

Abstract

The synthesis of human proinsulin fragment residues 40-60 by a solid phase method based on polydimethylacrylamide is described. Nineteen of the amino-acids were introduced as N alpha-(9-fluorenylmethoxycarbonyl) derivatives; functional side chains were protected as t-butyl ethers and esters. The yield of highly purified 21-residue peptide was 56.5%.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275009     DOI: 10.1515/bchm2.1981.362.2.833

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  4 in total

1.  Modulation of receptor binding to collagen by glycosylated 5-hydroxylysine: Chemical biology approaches made feasible by Carpino's Fmoc group.

Authors:  Maré Cudic; Gregg B Fields
Journal:  Pept Sci (Hoboken)       Date:  2020-03-19

2.  Synthetic peptides mimic gp75 from Paracoccidioides brasiliensis in the diagnosis of paracoccidioidomycosis.

Authors:  Camila Pistelli Caldini; Patricia Xander; Érika Seki Kioshima; André Luis Lacerda Bachi; Zoilo Pires de Camargo; Mário Mariano; José Daniel Lopes
Journal:  Mycopathologia       Date:  2012-01-17       Impact factor: 2.574

3.  Plasmodium vivax antigen discovery based on alpha-helical coiled coil protein motif.

Authors:  Nora Céspedes; Catherine Habel; Mary Lopez-Perez; Angélica Castellanos; Andrey V Kajava; Catherine Servis; Ingrid Felger; Remy Moret; Myriam Arévalo-Herrera; Giampietro Corradin; Sócrates Herrera
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

4.  Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.

Authors:  Nora Céspedes; Connie S N Li Wai Suen; Cristian Koepfli; Camila T França; Ingrid Felger; Issa Nebie; Myriam Arévalo-Herrera; Ivo Mueller; Giampietro Corradin; Sócrates Herrera
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.